Sep 08, 2021
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
Aug 19, 2021
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
Aug 04, 2021
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
Jul 12, 2021
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
Jul 08, 2021
Simulations Plus Celebrates 25 Years in Business
Jun 28, 2021
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
Jun 17, 2021
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
May 27, 2021
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference